Arthur Asao Sasahara, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urokinase-Type Plasminogen Activator | 18 | 2000 | 323 | 0.870 |
Why?
|
| Pulmonary Embolism | 48 | 2005 | 2598 | 0.660 |
Why?
|
| Thrombolytic Therapy | 10 | 2009 | 2059 | 0.590 |
Why?
|
| Fibrinolytic Agents | 23 | 2001 | 2080 | 0.530 |
Why?
|
| Streptokinase | 12 | 2000 | 185 | 0.350 |
Why?
|
| Publications | 1 | 2011 | 195 | 0.320 |
Why?
|
| Heparin | 21 | 2003 | 1630 | 0.300 |
Why?
|
| Hemodynamics | 19 | 2009 | 4184 | 0.250 |
Why?
|
| Scleroderma, Systemic | 1 | 2009 | 346 | 0.240 |
Why?
|
| Thrombophlebitis | 10 | 1992 | 286 | 0.230 |
Why?
|
| Secondary Prevention | 2 | 2009 | 1472 | 0.220 |
Why?
|
| Venous Thromboembolism | 5 | 2011 | 1882 | 0.220 |
Why?
|
| Thrombosis | 4 | 2011 | 2949 | 0.190 |
Why?
|
| Hypertension, Pulmonary | 5 | 2009 | 1604 | 0.180 |
Why?
|
| Plasminogen Activators | 2 | 1998 | 200 | 0.170 |
Why?
|
| Arterial Occlusive Diseases | 3 | 1998 | 729 | 0.160 |
Why?
|
| Leg | 4 | 1998 | 1080 | 0.130 |
Why?
|
| Radionuclide Imaging | 18 | 1989 | 1978 | 0.130 |
Why?
|
| Thromboembolism | 4 | 2001 | 1003 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2008 | 345 | 0.130 |
Why?
|
| Platelet Factor 4 | 2 | 1988 | 132 | 0.120 |
Why?
|
| Enzyme Precursors | 1 | 1994 | 164 | 0.120 |
Why?
|
| Anticoagulants | 8 | 2016 | 4862 | 0.110 |
Why?
|
| Pulmonary Circulation | 10 | 1986 | 741 | 0.110 |
Why?
|
| Hemorrhage | 9 | 2016 | 3461 | 0.110 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1996 | 516 | 0.100 |
Why?
|
| Enoxaparin | 2 | 2005 | 390 | 0.100 |
Why?
|
| beta-Thromboglobulin | 2 | 1988 | 20 | 0.090 |
Why?
|
| Organizations | 1 | 2011 | 172 | 0.090 |
Why?
|
| Angiography | 14 | 1986 | 1581 | 0.090 |
Why?
|
| Plethysmography, Impedance | 5 | 1983 | 44 | 0.080 |
Why?
|
| Myocardial Infarction | 5 | 1995 | 11499 | 0.070 |
Why?
|
| Recombinant Proteins | 5 | 2007 | 6493 | 0.070 |
Why?
|
| Dihydroergotamine | 1 | 1988 | 19 | 0.070 |
Why?
|
| Blood Specimen Collection | 1 | 1988 | 238 | 0.070 |
Why?
|
| Factor VII | 1 | 2007 | 139 | 0.070 |
Why?
|
| Acute Disease | 8 | 2005 | 7232 | 0.060 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1977 | 309 | 0.060 |
Why?
|
| Plasminogen | 4 | 1992 | 144 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 988 | 0.060 |
Why?
|
| Isoproterenol | 1 | 1984 | 398 | 0.060 |
Why?
|
| Pulmonary Artery | 13 | 1984 | 1935 | 0.050 |
Why?
|
| Blood Volume | 2 | 1982 | 542 | 0.050 |
Why?
|
| Drugs, Generic | 1 | 2008 | 456 | 0.050 |
Why?
|
| Humans | 71 | 2016 | 765968 | 0.050 |
Why?
|
| Blood Pressure | 13 | 2000 | 8532 | 0.050 |
Why?
|
| Disease Management | 2 | 2009 | 2535 | 0.050 |
Why?
|
| Hip Prosthesis | 1 | 1988 | 895 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 1983 | 371 | 0.040 |
Why?
|
| Lung | 10 | 1989 | 10033 | 0.040 |
Why?
|
| Vascular Resistance | 4 | 2000 | 941 | 0.040 |
Why?
|
| Cardiac Output | 7 | 1984 | 840 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1996 | 10729 | 0.040 |
Why?
|
| Preventive Medicine | 1 | 2001 | 246 | 0.040 |
Why?
|
| Coronary Circulation | 2 | 1995 | 1602 | 0.040 |
Why?
|
| Electrocardiography | 13 | 1989 | 6404 | 0.040 |
Why?
|
| Blood Coagulation Tests | 2 | 1994 | 263 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1982 | 686 | 0.040 |
Why?
|
| Microcirculation | 4 | 1986 | 1280 | 0.040 |
Why?
|
| Drug Administration Schedule | 3 | 2005 | 4850 | 0.040 |
Why?
|
| Aspirin | 3 | 1994 | 3134 | 0.040 |
Why?
|
| Angina Pectoris | 1 | 1982 | 956 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 5189 | 0.030 |
Why?
|
| Dextrans | 1 | 1979 | 571 | 0.030 |
Why?
|
| Postoperative Complications | 5 | 2009 | 15747 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4427 | 0.030 |
Why?
|
| Phlebography | 4 | 1983 | 328 | 0.030 |
Why?
|
| Radiography | 10 | 1989 | 6919 | 0.030 |
Why?
|
| Infusions, Parenteral | 3 | 1982 | 395 | 0.030 |
Why?
|
| Hospitalization | 3 | 2009 | 10808 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 1982 | 1316 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 1979 | 431 | 0.030 |
Why?
|
| Venous Thrombosis | 2 | 2003 | 1327 | 0.030 |
Why?
|
| Embolism | 1 | 1998 | 400 | 0.030 |
Why?
|
| Middle Aged | 21 | 2005 | 223009 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2007 | 2511 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 9747 | 0.030 |
Why?
|
| Recurrence | 3 | 2000 | 8501 | 0.030 |
Why?
|
| Heart Ventricles | 6 | 1984 | 3832 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7425 | 0.020 |
Why?
|
| Exercise Test | 1 | 2000 | 2180 | 0.020 |
Why?
|
| Vascular Patency | 1 | 1994 | 912 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1975 | 759 | 0.020 |
Why?
|
| Dogs | 5 | 1991 | 3822 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2016 | 966 | 0.020 |
Why?
|
| Pulmonary Heart Disease | 3 | 1984 | 33 | 0.020 |
Why?
|
| Drug Evaluation | 2 | 1982 | 641 | 0.020 |
Why?
|
| Time Factors | 5 | 2000 | 40065 | 0.020 |
Why?
|
| Male | 22 | 2005 | 363698 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1973 | 608 | 0.020 |
Why?
|
| Clinical Trials as Topic | 5 | 1988 | 8041 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1996 | 6203 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 3432 | 0.020 |
Why?
|
| Capillaries | 2 | 1984 | 755 | 0.020 |
Why?
|
| Heart Diseases | 3 | 1977 | 2821 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2016 | 1055 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 1996 | 12437 | 0.020 |
Why?
|
| Fibrinolysis | 2 | 1986 | 331 | 0.020 |
Why?
|
| Echocardiography | 1 | 1980 | 5045 | 0.020 |
Why?
|
| Aged | 15 | 2003 | 171117 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1988 | 860 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 1987 | 152 | 0.020 |
Why?
|
| Ischemia | 1 | 1996 | 1909 | 0.020 |
Why?
|
| Myocardium | 3 | 1980 | 4760 | 0.020 |
Why?
|
| Risk | 2 | 1998 | 9591 | 0.020 |
Why?
|
| Oxygen | 6 | 1984 | 4241 | 0.020 |
Why?
|
| Female | 14 | 2005 | 396112 | 0.020 |
Why?
|
| Vena Cava, Inferior | 1 | 1969 | 463 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 1971 | 704 | 0.020 |
Why?
|
| Survival Rate | 1 | 2000 | 12795 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1998 | 10070 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2000 | 39193 | 0.010 |
Why?
|
| Heart | 3 | 1974 | 4414 | 0.010 |
Why?
|
| Catheterization, Peripheral | 1 | 1988 | 349 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2016 | 2192 | 0.010 |
Why?
|
| Lung Diseases | 3 | 1984 | 1940 | 0.010 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 1977 | 418 | 0.010 |
Why?
|
| Adult | 16 | 2003 | 223044 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2009 | 1195 | 0.010 |
Why?
|
| Random Allocation | 1 | 1988 | 2395 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2008 | 1391 | 0.010 |
Why?
|
| Dipyridamole | 1 | 1983 | 137 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1994 | 4493 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 65188 | 0.010 |
Why?
|
| Serum Albumin, Radio-Iodinated | 2 | 1972 | 37 | 0.010 |
Why?
|
| Prospective Studies | 3 | 1996 | 54802 | 0.010 |
Why?
|
| Lidoflazine | 1 | 1982 | 1 | 0.010 |
Why?
|
| Xenon | 2 | 1973 | 120 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1995 | 8733 | 0.010 |
Why?
|
| Administration, Oral | 2 | 1984 | 4015 | 0.010 |
Why?
|
| Technetium | 2 | 1972 | 326 | 0.010 |
Why?
|
| Prognosis | 3 | 2016 | 29922 | 0.010 |
Why?
|
| Nifedipine | 1 | 1982 | 220 | 0.010 |
Why?
|
| Diltiazem | 1 | 1982 | 132 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1988 | 2077 | 0.010 |
Why?
|
| Diagnosis, Differential | 5 | 1977 | 12976 | 0.010 |
Why?
|
| Verapamil | 1 | 1982 | 242 | 0.010 |
Why?
|
| Kinins | 1 | 1980 | 14 | 0.010 |
Why?
|
| Coronary Disease | 2 | 1988 | 5912 | 0.010 |
Why?
|
| Fibrinogen | 3 | 1976 | 895 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 13400 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 1984 | 15652 | 0.010 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1980 | 93 | 0.010 |
Why?
|
| Heart Aneurysm | 1 | 1980 | 115 | 0.010 |
Why?
|
| Platelet Count | 1 | 1983 | 782 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 1980 | 192 | 0.010 |
Why?
|
| Respiration | 1 | 1966 | 1653 | 0.010 |
Why?
|
| Captopril | 1 | 1980 | 261 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1171 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 17594 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1983 | 769 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1991 | 1377 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1980 | 396 | 0.010 |
Why?
|
| Pain | 2 | 1977 | 5077 | 0.010 |
Why?
|
| Proline | 1 | 1980 | 453 | 0.010 |
Why?
|
| Risk Factors | 3 | 2016 | 74840 | 0.010 |
Why?
|
| Clothing | 1 | 1979 | 95 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1991 | 5125 | 0.010 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1980 | 477 | 0.010 |
Why?
|
| Coronary Vessels | 2 | 1982 | 3096 | 0.010 |
Why?
|
| Joint Prosthesis | 1 | 1979 | 233 | 0.010 |
Why?
|
| Angiotensin II | 1 | 1980 | 844 | 0.010 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2003 | 645 | 0.010 |
Why?
|
| Warfarin | 1 | 2005 | 1494 | 0.010 |
Why?
|
| Partial Pressure | 2 | 1975 | 245 | 0.010 |
Why?
|
| Thrombectomy | 1 | 2001 | 681 | 0.010 |
Why?
|
| Blood Gas Analysis | 2 | 1967 | 380 | 0.010 |
Why?
|
| Pressure | 1 | 1979 | 1168 | 0.010 |
Why?
|
| Hemoptysis | 1 | 1977 | 150 | 0.010 |
Why?
|
| Aldosterone | 1 | 1980 | 881 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1980 | 1515 | 0.010 |
Why?
|
| Pleura | 1 | 1977 | 240 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 2692 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2016 | 24282 | 0.010 |
Why?
|
| Tachycardia | 1 | 1977 | 594 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1974 | 116 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1974 | 193 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 18071 | 0.010 |
Why?
|
| Regional Blood Flow | 2 | 1974 | 1478 | 0.010 |
Why?
|
| Incidence | 1 | 1992 | 21480 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1982 | 9347 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1974 | 317 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1977 | 346 | 0.010 |
Why?
|
| Cineangiography | 1 | 1972 | 108 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 1979 | 635 | 0.010 |
Why?
|
| Snakes | 1 | 1973 | 27 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 1973 | 114 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1972 | 181 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18380 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1979 | 1470 | 0.010 |
Why?
|
| Neurosurgery | 1 | 1979 | 683 | 0.010 |
Why?
|
| Venoms | 1 | 1973 | 94 | 0.010 |
Why?
|
| Hip Joint | 1 | 1979 | 1000 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 1981 | 902 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 5302 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1974 | 626 | 0.010 |
Why?
|
| Respiratory Function Tests | 3 | 1972 | 1693 | 0.010 |
Why?
|
| Microspheres | 1 | 1974 | 773 | 0.010 |
Why?
|
| alpha-Macroglobulins | 1 | 1991 | 60 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1973 | 495 | 0.010 |
Why?
|
| Fibrinolysin | 1 | 1991 | 129 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1971 | 196 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1984 | 5596 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1977 | 1315 | 0.010 |
Why?
|
| Heart Rate | 2 | 1971 | 4204 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1972 | 675 | 0.010 |
Why?
|
| Length of Stay | 1 | 2003 | 6485 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2001 | 1941 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1975 | 1668 | 0.000 |
Why?
|
| Iliac Vein | 1 | 1969 | 73 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1973 | 1602 | 0.000 |
Why?
|
| Cough | 1 | 1973 | 597 | 0.000 |
Why?
|
| Femoral Vein | 1 | 1969 | 157 | 0.000 |
Why?
|
| Posture | 1 | 1972 | 954 | 0.000 |
Why?
|
| Spinal Cord Injuries | 1 | 1976 | 927 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1980 | 2067 | 0.000 |
Why?
|
| United States | 2 | 1992 | 72903 | 0.000 |
Why?
|
| Pneumoconiosis | 1 | 1966 | 32 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1991 | 811 | 0.000 |
Why?
|
| Perfusion | 1 | 1971 | 1407 | 0.000 |
Why?
|
| Research Design | 1 | 1982 | 6209 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1975 | 6309 | 0.000 |
Why?
|
| Dyspnea | 1 | 1973 | 1352 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1973 | 1240 | 0.000 |
Why?
|
| Animals | 5 | 1991 | 168764 | 0.000 |
Why?
|
| Disease Models, Animal | 2 | 1991 | 18293 | 0.000 |
Why?
|
| Carbon | 1 | 1966 | 677 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1988 | 59489 | 0.000 |
Why?
|
| Blood Coagulation | 1 | 1967 | 1166 | 0.000 |
Why?
|
| Pneumonia | 1 | 1973 | 2157 | 0.000 |
Why?
|
| Hydrochlorothiazide | 1 | 1980 | 95 | 0.000 |
Why?
|
| Heart Failure | 2 | 1975 | 11840 | 0.000 |
Why?
|
| Contrast Media | 1 | 1972 | 5329 | 0.000 |
Why?
|
| Pregnancy | 1 | 2001 | 30260 | 0.000 |
Why?
|
| Diet, Sodium-Restricted | 1 | 1980 | 291 | 0.000 |
Why?
|
| Renin | 1 | 1980 | 647 | 0.000 |
Why?
|
| Heart Atria | 2 | 1975 | 1363 | 0.000 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1980 | 1514 | 0.000 |
Why?
|
| Dilatation | 1 | 1975 | 310 | 0.000 |
Why?
|
| Bundle-Branch Block | 1 | 1975 | 280 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1976 | 1029 | 0.000 |
Why?
|
| Cardiomegaly | 1 | 1975 | 589 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1972 | 412 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1972 | 415 | 0.000 |
Why?
|
| Heart Conduction System | 1 | 1972 | 1006 | 0.000 |
Why?
|
| Occupations | 1 | 1966 | 516 | 0.000 |
Why?
|
| Hypertension | 1 | 1980 | 8626 | 0.000 |
Why?
|